Kkr Healthcare Strategic Growth Fund L.p. - Net Worth and Insider Trading
Kkr Healthcare Strategic Growth Fund L.p. Net Worth
The estimated net worth of Kkr Healthcare Strategic Growth Fund L.p. is at least $12 Million dollars as of 2024-05-31. Kkr Healthcare Strategic Growth Fund L.p. is the 10% Owner of Oyster Point Pharma Inc and owns about 1,039,622 shares of Oyster Point Pharma Inc (OYST) stock worth over $12 Million. Kkr Healthcare Strategic Growth Fund L.p. is also the 10% Owner of IPI Legacy Liquidation Co and owns about 3,802,638 shares of IPI Legacy Liquidation Co (IMPLQ) stock worth over $57,040. Details can be seen in Kkr Healthcare Strategic Growth Fund L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kkr Healthcare Strategic Growth Fund L.p. has not made any transactions after 2021-04-27 and currently still holds the listed stock(s).
Transaction Summary of Kkr Healthcare Strategic Growth Fund L.p.
Kkr Healthcare Strategic Growth Fund L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kkr Healthcare Strategic Growth Fund L.p. owns 2 companies in total, including Oyster Point Pharma Inc (OYST) , and IPI Legacy Liquidation Co (IMPLQ) .
Insider Ownership Summary of Kkr Healthcare Strategic Growth Fund L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OYST | Oyster Point Pharma Inc | 2019-11-04 | 10 percent owner |
| IMPLQ | IPI Legacy Liquidation Co | 2021-04-27 | 10 percent owner |
Kkr Healthcare Strategic Growth Fund L.p. Latest Holdings Summary
Kkr Healthcare Strategic Growth Fund L.p. currently owns a total of 2 stocks. Among these stocks, Kkr Healthcare Strategic Growth Fund L.p. owns 1,039,622 shares of Oyster Point Pharma Inc (OYST) as of November 4, 2019, with a value of $12 Million and a weighting of 99.51%. Kkr Healthcare Strategic Growth Fund L.p. also owns 3,802,638 shares of IPI Legacy Liquidation Co (IMPLQ) as of April 27, 2021, with a value of $57,040 and a weighting of 0.49%.
Latest Holdings of Kkr Healthcare Strategic Growth Fund L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OYST | Oyster Point Pharma Inc | 2019-11-04 | 1,039,622 | 11.17 | 11,612,578 |
| IMPLQ | IPI Legacy Liquidation Co | 2021-04-27 | 3,802,638 | 0.02 | 57,040 |
Holding Weightings of Kkr Healthcare Strategic Growth Fund L.p.
Kkr Healthcare Strategic Growth Fund L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Kkr Healthcare Strategic Growth Fund L.p. has made a total of 1 transactions in Oyster Point Pharma Inc (OYST) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Oyster Point Pharma Inc is the acquisition of 155,000 shares on November 4, 2019, which cost Kkr Healthcare Strategic Growth Fund L.p. around $2 Million.
According to the SEC Form 4 filings, Kkr Healthcare Strategic Growth Fund L.p. has made a total of 1 transactions in IPI Legacy Liquidation Co (IMPLQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in IPI Legacy Liquidation Co is the acquisition of 1,100,000 shares on April 27, 2021, which cost Kkr Healthcare Strategic Growth Fund L.p. around $17 Million.
Insider Trading History of Kkr Healthcare Strategic Growth Fund L.p.
- 1
Kkr Healthcare Strategic Growth Fund L.p. Trading Performance
GuruFocus tracks the stock performance after each of Kkr Healthcare Strategic Growth Fund L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kkr Healthcare Strategic Growth Fund L.p. is 31.27%. GuruFocus also compares Kkr Healthcare Strategic Growth Fund L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Kkr Healthcare Strategic Growth Fund L.p. within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kkr Healthcare Strategic Growth Fund L.p.'s insider trading performs compared to the benchmark.
Performance of Kkr Healthcare Strategic Growth Fund L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.36 | | | | | |
| Relative Return to S&P 500(%) | -13.09 | | | | | |
Kkr Healthcare Strategic Growth Fund L.p. Ownership Network
Kkr Healthcare Strategic Growth Fund L.p. Owned Company Details
What does Oyster Point Pharma Inc do?
Who are the key executives at Oyster Point Pharma Inc?
Kkr Healthcare Strategic Growth Fund L.p. is the 10 percent owner of Oyster Point Pharma Inc. Other key executives at Oyster Point Pharma Inc include director & 10 percent owner Link William J Phd , 10 percent owner Versant Venture Capital Vi, L.p. , and Chief Commercial Officer John Snisarenko .
Oyster Point Pharma Inc (OYST) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Oyster Point Pharma Inc (OYST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oyster Point Pharma Inc (OYST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Oyster Point Pharma Inc (OYST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oyster Point Pharma Inc Insider Transactions
Kkr Healthcare Strategic Growth Fund L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Kkr Healthcare Strategic Growth Fund L.p.. You might contact Kkr Healthcare Strategic Growth Fund L.p. via mailing address: C/o Kohlberg Kravis Roberts & Co. L.p., 9 West 57th Street, Suite 4200, New York Ny 10019.
Discussions on Kkr Healthcare Strategic Growth Fund L.p.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
